ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023

Go back to ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023

ResMed (RMD) Tops Q3 EPS by 9c

April 27, 2023 4:13 PM EDT

ResMed (NYSE: RMD) reported Q3 EPS of $1.68, $0.09 better than the analyst estimate of $1.59. Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.05 billion.

For earnings history and earnings-related data on ResMed (RMD) click here.

... More